“No memberships, no minimums, no commitments” is a clear sales proposition, but it does not answer every question about a prescription purchase. At The Pharmacy Place, the medical questionnaire follows checkout, while a prescription remains conditional on clinical approval. That makes the sequence important: before paying, a prospective patient should understand what happens if treatment is declined, an order is canceled or a shipment has a problem. The consulted pages explain parts of that process without establishing a complete refund policy.
The Pharmacy Place describes itself as a compounding pharmacy in Peachtree City, Georgia, preparing injectable semaglutide and tirzepatide and coordinating telehealth evaluation. This review examines its public documentation consulted October 19, 2026, with particular attention to enrollment, financial commitments and responsibility for service problems. The offering has several concrete inclusions, but different pages show different tirzepatide price ceilings, and geographic availability requires confirmation. Those are reasons to obtain written terms—not proof that the pharmacy cannot provide the advertised service.
At a glance
- Business and preparation
- The Pharmacy Place describes itself as a Peachtree City compounding pharmacy that prepares medication in-house; its licensing claims were not independently verified for this review.Sources: [7]
- Checkout before assessment
- Product instructions say a secure medical questionnaire arrives after checkout. Prescription issuance and pharmacy processing depend on clinical approval.Sources: [6]
- Published prices
- The program page lists semaglutide at $139–$179 per month and tirzepatide at $179–$279 per month. The tirzepatide product listing instead displays $179–$299 without defining the supply period in the quoted heading.
- Included charges
- The pharmacy advertises no memberships, minimums or commitments. Product listings include shipping, injection supplies and a physician consultation identified as a $20 fee included in the price.
- Returns are not refunds
- The pharmacy says medication cannot be returned after leaving its facility. That statement does not establish refund rights for clinical denial, cancellation or delivery problems.Sources: [8]
The first commitment happens before the medical decision
The product-page enrollment sequence begins with checkout, followed by a secure link to a medical questionnaire. The pharmacy asks purchasers to complete it promptly to avoid delays. Separately, the program page describes a form covering health, lifestyle and medical history, reviewed by a licensed physician who develops a treatment plan and prescribes if appropriate. Checkout therefore is not the same event as approval, and the public instructions do not establish that everyone purchasing will receive medication.
The advertised eligibility description covers adults 18 or older who are not pregnant or breastfeeding and do not have certain conditions that could make treatment unsafe. The consulted documentation does not provide the full condition list, required laboratory testing or complete clinical criteria. Nor does it identify the external clinical entity or individual evaluating physicians. A prospective purchaser should ask which organization provides the evaluation and how an unsuccessful assessment affects the payment.
The most consequential missing term is the financial outcome of clinical denial. The documentation reviewed does not clarify whether a declined patient receives a full refund, whether any amount is retained or when a refund would be processed. The practical use of an enrollment-terms checklist here is to resolve that specific gap before checkout, rather than assume that conditional prescribing automatically means conditional payment.
No membership is useful, but repeat-order terms remain incomplete
The pharmacy’s homepage says, “No memberships, no minimums, no commitments, no shipping fee. You pay only for your medication.” Its program page likewise advertises no membership, consultation or shipping fees and no hidden fees. These statements describe a comparatively straightforward commercial offer: medication purchasing rather than a separately priced membership. They do not, however, supply the operational details needed to determine how a second order is authorized, billed or stopped.
The consulted pages do not establish recurring-charge conditions, a renewal calendar, a cancellation notice deadline or the mechanism for requesting another supply. They also do not document mandatory multi-month prepayment, installment alternatives or a discount arrangement. None should be assumed. In particular, a monthly advertised price does not by itself establish automatic monthly billing, just as the absence of a membership does not explain whether a saved payment method may be charged for an authorized refill.
Before enrolling, ask whether each order requires affirmative approval, whether any payment authorization continues after the first purchase and who can stop an order already being prepared. Request the answer alongside the actual supply period. The distinction between a monthly price and an ongoing commitment matters especially here because semaglutide options include an initial six-week supply and other four-week options; those are not interchangeable calendar-month descriptions.
Match the quoted price to the exact product and period
The program page advertises compounded injectable semaglutide starting at $139 per month and reaching $179 per month depending on dose. It advertises compounded injectable tirzepatide starting at $179 and reaching $279 per month. The product listings display $139–$179 for semaglutide but $179–$299 for tirzepatide. That higher tirzepatide ceiling is a genuine documentation difference; the quoted product heading does not specify a supply period that would resolve it.
Both product listings state that shipping and all injection supplies are included. They also identify a $20 doctor consultation fee as included in the price, rather than an additional charge. The program’s broader “no consultation fee” language is therefore best read alongside that inclusion: the pages do not show a separate $20 surcharge. The service is advertised as cash-pay with no insurance required, not as a documented insurance-billing program.
A useful written quote would name the medication, formulation, subcutaneous route, selected presentation, supply duration and final charge. It should also confirm the included consultation and supplies. The pharmacy describes its compounded injections as enhanced with B vitamins, but the consulted text does not specify each vitamin or product composition. Price comparisons are incomplete until the pharmacy explains both the selected formulation and whether the purchase covers six weeks, four weeks or another stated period.
| Offering or term | What the pages state | Before paying, confirm |
|---|---|---|
| Compounded injectable semaglutide | Program: starts at $139/month, up to $179/month depending on dose; product range: $139–$179 | Selected presentation and whether it is the initial six-week or a four-week option |
| Compounded injectable tirzepatide | Program: starts at $179/month, up to $279/month; product range: $179–$299 | Final charge and supply period; the product heading does not define that period |
| Consultation | $20 doctor consultation fee included in product price | Financial outcome if clinical approval is declined |
| Shipping and administration supplies | Shipping and all injection supplies included | Delivery address eligibility and problem-resolution terms |
| Continuing purchases | No memberships, minimums or commitments advertised | How refills are authorized, charged and canceled |
Cancellation, returns and refunds are separate questions
The clearest return boundary is that The Pharmacy Place cannot accept medication back once it has left the pharmacy. That is a statement about accepting returned medication, not a complete statement about money. It does not establish whether an order can be canceled before preparation, whether a payment can be refunded after a clinical denial or whether a damaged or missing shipment qualifies for replacement or reimbursement.
For a lost or delayed package, the program page directs patients to contact the pharmacy immediately so it can work to resolve the issue. That is a useful contact instruction, but it does not promise a replacement, define responsibility for carrier loss or specify a refund timetable. The public documentation also leaves quality-related financial remedies unclear. A purchaser should avoid treating a willingness to investigate as a guaranteed outcome.
The practical questions are stage-specific: can payment be reversed before clinical review, after approval but before preparation, or before dispatch? Who decides, and are any charges retained? Ask separately what happens when the pharmacy or carrier cannot complete delivery. A guide to refund boundaries can help frame those questions, but only the pharmacy’s actual written policy can resolve them. No refund-arrival deadline is established in the consulted pages.
Know which organization owes which part of the service
The Pharmacy Place presents itself as a pharmacy, not merely an online intermediary, and says it prepares medications in-house. It identifies Hiren Patel as founder, pharmacist and owner. Its published team also includes Charley Nowicki as clinical pharmacist liaison, Tiffany Turner as pharmacist and Neil Patel as compounding lead technician. These details identify the business’s stated personnel and functions; they do not independently verify licenses, credentials or the quality of a particular preparation.
Prescribing is described as coordinated through a telehealth platform with a provider specializing in weight management. The detailed consultation description specifies physician review, while the pharmacy handles preparation after approval and offers ongoing pharmacy-team support. The documentation does not identify the separate clinical organization, explain its contractual relationship with the pharmacy or assign a frequency for follow-up visits. Included initial consultation should not be expanded into an assumption of unlimited clinician appointments.
This division matters when deciding whom to contact about treatment questions, prescription changes and payment disputes. Ask for the prescriber’s contact pathway as well as the pharmacy’s. A map of platform, clinician and pharmacy responsibilities is particularly relevant when a single checkout appears to bundle several organizations’ work. The pharmacy also claims LegitScript certification and multi-state licensing; this review reports those statements without treating them as independently checked credentials.
Delivery promises start at different points in the process
The website offers several timing descriptions, and each starts at a different milestone. The homepage says most orders ship within one to two business days after prescription approval. The program page says the physician typically sends the prescription within one to two days of the consultation. It also says prescriptions received in the morning usually ship that day, while afternoon prescriptions ship the following business day. Those statements describe different steps, not one interchangeable countdown.
The program additionally claims that most patients receive medication within 72 hours of the online consultation. That is an advertised typical experience, not a guaranteed arrival commitment, and it should be read alongside the earlier review and dispatch estimates. The listed shipping method is UPS Next-Day with temperature-controlled packaging. Alcohol swabs, syringes and other administration supplies are included. Product instructions promise a processing notification and tracking information once the package ships.
For an injectable that arrives warm or with insufficient refrigeration, FDA explicitly recommends not using it and contacting the provider or dispensing pharmacy. General website statements about stability do not settle the condition of an individual shipment. Before ordering, ask which contact handles temperature concerns, what information it needs and how replacement or refund decisions are made. Free shipping does not answer those service-recovery questions, and dispatch is not the same as arrival.
Confirm your state and preserve a usable contact path
The pharmacy lists its address as 2035 Commerce Dr N, Peachtree City, GA 30269, with general telephone number 678-271-3970. The program page gives a separate direct number, 833-586-3111, and says a pharmacist is available to answer questions. Its homepage describes ongoing pharmacy support during treatment. The consulted documentation does not establish support hours, guaranteed response times, Spanish-language service or a schedule of clinical reevaluations.
Geography is another prepayment question. The homepage says the business currently serves patients throughout the Southeast and plans nationwide expansion. Another page says it is licensed in multiple states and asks readers to contact it to confirm their state. The consulted documentation does not provide a complete state list or license numbers for independent coverage verification. Promotional references to patients across the country do not establish nationwide availability for every prospective purchaser.
Communication consent is more explicit than several purchasing terms. The privacy policy says marketing-message consent is not required to buy goods or services and can be withdrawn. It permits SMS opt-out by replying STOP, with a confirmation and an exception for administrative communications. That is not the same as canceling an order or prescription service. Anyone seeking to stop a purchase should obtain a separate order-status confirmation rather than rely on a marketing opt-out.
A complete purchase agreement would not establish clinical results
The Pharmacy Place acknowledges that compounded medications are not FDA approved and are not evaluated by FDA for safety, effectiveness or quality. Its description of B-vitamin-enhanced injections also attributes energy and metabolism benefits to those preparations. Those are provider marketing claims, not independent clinical findings about its products. The consulted documentation does not establish the precise vitamin composition of each offering or clinical outcomes for patients receiving these particular formulations.
FDA recommends compounded drugs when an individual’s medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not prove clinical inequivalence, but it also does not establish equivalence with a specific approved product. FDA has reported measurement and administration errors involving compounded medication. The pharmacy says it teaches preparation and injection; patients should clarify instructions with the prescriber or pharmacist rather than derive them from a review.
The pharmacy’s website terms warn that materials may contain errors and are not guaranteed to be accurate, complete or current. That disclaimer makes reconciliation of the conflicting prices especially important; it does not identify which listing controls a particular order. Keep the final quote, product description and answers about cancellation and follow-up together. Clear commercial documentation can improve decision preparation, but it cannot substitute for an individualized clinical evaluation or demonstrate treatment effectiveness.
Questions & answers
Does The Pharmacy Place require a subscription?
It advertises no memberships, minimums or commitments. However, the consulted pages do not explain repeat-order authorization, recurring payment rules or a cancellation deadline. Ask whether every refill requires your approval and whether any payment authorization continues after the initial order. The monthly advertised price alone does not establish a subscription or its absence.
Will I get a refund if the physician does not prescribe?
The public documentation reviewed does not answer that question. The medical questionnaire follows checkout, and prescribing depends on approval, so the issue is material before purchase. Ask whether clinical denial produces a full refund, whether anything is retained and when processing occurs. The rule against accepting returned medication does not resolve a denial before dispensing.
Why are two different tirzepatide maximum prices shown?
The program page lists a starting price of $179 per month and a maximum of $279 per month, while the product listing displays $179–$299. The quoted product heading does not define its supply period. The consulted documentation does not reconcile the difference. Obtain the final charge for the exact compounded injectable presentation and duration before paying.
Are the consultation, shipping and syringes extra?
The product listings include shipping, all injection supplies and a doctor consultation identified as a $20 fee included in the price. The program page likewise advertises no separate consultation or shipping fees. That does not establish unlimited follow-up appointments: the consulted pages do not specify a clinical visit schedule or the conditions for later prescription renewals.
Can the pharmacy ship to any U.S. state?
Nationwide availability is not confirmed. The homepage describes current service in the Southeast and future national expansion, while another page says the pharmacy holds licenses in multiple states and asks patients to check availability. Contact the pharmacy with your delivery state before checkout. A Georgia address or a general online ordering option does not establish service eligibility elsewhere.
Who should I contact about a delayed or warm shipment?
The program tells patients to contact The Pharmacy Place immediately about lost or delayed packages and lists 833-586-3111 as a direct contact number. For an injectable arriving warm or inadequately refrigerated, FDA advises not using it and contacting the provider or dispensing pharmacy. The reviewed documentation does not promise a specific refund or replacement outcome.
Our assessment
The Pharmacy Place documents a pharmacy-centered offer with several useful commercial specifics: cash payment, no advertised membership or minimum commitment, an included consultation, injection supplies and shipping. It also describes the assessment-to-prescription process and provides direct pharmacy contact paths. The weaker area is the boundary between purchasing and receiving care. Checkout precedes clinical review, but denial refunds, pre-dispatch cancellation, repeat-order authorization and delivery remedies are not fully explained. The conflicting tirzepatide maximum and differing supply periods make a product-specific written quote important. For an adult considering this service, the most useful next step is to confirm state availability and obtain those missing terms before paying. Neither the advertised simplicity nor the documentation gaps alone establish clinical quality; the purchase terms and the individual treatment decision require separate scrutiny.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- The Pharmacy Place — privacy policy ↗
- The Pharmacy Place — product/tirzepatide ↗
- The Pharmacy Place — about us ↗
- The Pharmacy Place — terms and conditions ↗
- The Pharmacy Place — product/semaglutide ↗
- The Pharmacy Place — official website ↗
- The Pharmacy Place — glp1 weight loss injections ↗